About
Dr. Greg Bailey is a physician-turned-biotech entrepreneur and financier best known as co-founder and executive chairman of Juvenescence, the longevity-focused biotech investment and drug-development platform. He previously served as managing partner of Palantir Group and has held board or financing roles across companies including Biohaven, Portage Biotech, SalvaRx and Manx Financial Group. He is also active as a longevity-media voice through the 'Longevity for Investors' podcast.
Areas of interest
longevityanti-aging therapeuticsgerosciencesenolyticsepigenetic reprogrammingNAD+ biologybiotechdrug discoveryAI/ML in drug discoverycomputational biologyneurodegenerative diseaseoncologyorgan regenerationmetabolic diseasespecialty pharmacellular agriculturedeep techhealthspan extension